J. E. van Hooft
University of Amsterdam
36 Papers
251 Citations
J. E. van Hooft is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Stent & Medicine. The author has an hindex of 18, co-authored 36 publications.
Chat about Author
Papers
Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial
D. A. M. Sloothaak,M. W. van den Berg,Marcel G. W. Dijkgraaf,P. Fockens,Pieter J. Tanis,J. E. van Hooft,W. A. Bemelman +6 more
TL;DR: The Stent‐In 2 trial randomized patients with malignant colonic obstruction to emergency surgery or stent placement as a bridge to elective surgery to compare the oncological outcomes.
A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals
Femme Harinck,Ingrid C. Konings,Irma Kluijt,Jan-Werner Poley,J. E. van Hooft,H. M. van Dullemen,Chung Y. Nio,Nanda C. Krak,John J. Hermans,C M Aalfs,Anja Wagner,Rolf H. Sijmons,Katharina Biermann,C.H.J. van Eijck,D J Gouma,Marcel G. W. Dijkgraaf,Paul Fockens,Marco J. Bruno +17 more
TL;DR: Both imaging techniques were complementary rather than interchangeable: contrary to EUS, MRI was found to be very sensitive for the detection of cystic lesions of any size; MRI, however, might have some important limitations with regard to the timely detection of solid lesions.
180
Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer.
J. E. van Hooft,Paul Fockens,Andreas Marinelli,Robin Timmer,A. M. van Berkel,Patrick M.M. Bossuyt,W. A. Bemelman +6 more
TL;DR: The unexpected high rate of perforation in the nonsurgical arm might be specifically WallFlex-related or enteral stent-related in patients on chemotherapy and warrants attention.
127
Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience
Fadi Rassam,E. Roos,K.P. van Lienden,J. E. van Hooft,Heinz-Josef Klümpen,G. van Tienhoven,Roel J. Bennink,Marc R. W. Engelbrecht,Annuska Schoorlemmer,Ulrich Beuers,J. Verheij,Marc G. Besselink,O.R.C. Busch,T.M. van Gulik +13 more
TL;DR: Upcoming diagnostic modalities such as Spyglass and combinations of serum biomarkers and molecular markers have potential to decrease the rate of misdiagnosis of benign, inflammatory disease.
Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction.
Femke J. Amelung,Wernard A. A. Borstlap,Esther C. J. Consten,Joyce V. Veld,E. E. van Halsema,W. A. Bemelman,Peter D. Siersema,F. ter Borg,J. E. van Hooft,Pieter J. Tanis +9 more
TL;DR: Long‐term oncological outcomes between emergency resection and SEMS placement as BTS in patients with left‐sided obstructing colonic cancer are compared.
90